Development of Novel Biomarkers to Inform Decision Making in Surgical Patients with Urothelial Cancer

Live lecture format. Noon conference series on a variety of didactic topics.

Launch Date: 11/22/2022

Expiration Date: 11/22/2023

1. Understand the concept of liquid biopsy
2. Understand the relevance/appeal of bladder sparing approaches in bladder cancer
3. Understand how liquid biopsy might improve the prospect of bladder sparing for bladder cancer patients

How to obtain CE credits:

Please note, you have to watch the entire video in order to receive any CE credit for this online activity.

Sign in or create a new account by clicking "Sign In" in top left corner. *If you previously participated in a CME activity accredited by IUSM  but do not know your password, please enter your email address and click on the 'Forget Your Password' link. Your password will be emailed to you.

1. Click the Tests tile > Launch Video to view the module.
2. After viewing the video go back to the Tests tile and click Post-Test to attest to completing the activity.
3. Click the MyCME button > Evaluations and Certificates
4. Find the activity name in the list and click Complete Evaluation.
5. Click Submit.
6. On the Evaluations and Certificates page, click Download Certificate or access your transcript through the Transcript tile.
   

Please note that you are not able to claim credit if you already attended the live conference on October 28, 2022.

In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and Indiana University Health Bloomington Hospital. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians 

Physicians Indiana University School of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all financial relationships with any ineligible companies so that IUSM may identify and mitigate any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

There are no relevant financial relationship(s) with ineligible companies for anyone who was in control of the content of this activity, except:

Philip Abbosh, MD, PhD has disclosed being a consultant for Janssen, Natera, Imax, and receiving research support from Janssen, and Natera.

All conflict have been mitigated.

List of References:

1.      J Urol 205:1605 

2.      Eur Urol 79:364

3.      JCO 20:32

4.      Cell Reports 26:2241

5.      Science 370:75 

6.      JAMA Oncology 154: e191629

7.      Medical Care 33:828

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

Mitigation of Relevant Financial Relationships